Tracking

Wegovy Tracker Guide: Dose Schedule, Side Effects, and Weight Logging

GLP-1 Companion · 6 min read

Wegovy tracking is different because the first four months are a staircase. If your log only records weight, you miss the part that explains most of the experience: dose escalation, side effects, missed-dose windows, and whether the pace is sustainable.

My position: a Wegovy tracker is worth using if it protects the treatment plan. That means clean dose history, side-effect severity, weight trend, and enough documentation for follow-ups and prior-authorization renewals.

The Five Things to Log Every Week

• Injection date and time.
• Dose (0.25, 0.5, 1.0, 1.7, 2.4 mg).
• Injection site — abdomen, thigh, or upper arm; left or right.
• Side effects on a 1–10 scale (nausea, fatigue, GI, headache).
• Weight, same morning each week.

Wegovy Titration Schedule (16+ Weeks)

Wegovy escalates over 16 weeks before reaching its target maintenance dose. This is intentional — slower titration reduces GI side effects. Log every escalation date.

1. Weeks 1–4: 0.25 mg weekly.
2. Weeks 5–8: 0.5 mg weekly.
3. Weeks 9–12: 1.0 mg weekly.
4. Weeks 13–16: 1.7 mg weekly.
5. Week 17+: 2.4 mg weekly (target maintenance dose).

Wegovy Missed-Dose Rule

Different from Ozempic: if more than 2 days remain until the next scheduled dose, take the missed dose. If 2 days or fewer remain, skip it and resume on schedule. Do not double up. If you miss for more than 2 consecutive weeks, your provider may restart the titration at a lower dose — making your log critical.

Pen Format

Wegovy is a single-dose pen — one pen per weekly injection. The dose strength matches the label color: 0.25 (light gray), 0.5 (red), 1.0 (yellow), 1.7 (light blue), 2.4 (dark blue). Recording the strength in your log is a backup against pen confusion during a titration transition.

Side Effects Worth Logging for Wegovy

• Nausea — most common; typically peaks days 2–4 after a fresh injection at a new dose level.
• GI distress — diarrhea or constipation are both common.
• Fatigue — clusters in the first 1–2 weeks of a new dose.
• Reflux and burping (sometimes sulfur burps) — common on semaglutide.
• Mood changes — log on a 1–10 scale weekly; emerging GLP-1 mood literature is mixed but real.
• Injection-site reactions — log site and any reaction together.

Weight Tracking on Wegovy

The STEP 1 trial showed average weight loss of ~14.9% at 68 weeks on the full 2.4 mg dose. Your trajectory depends heavily on whether you remain at full dose, your starting weight, and your lifestyle. Track weekly weight, monthly waist and hips, and monthly photos. The most important variable in your tracking is consistency, not frequency — once a week is sufficient.

• Weeks 1–8: small early losses (often water-driven).
• Months 3–9: steepest sustained loss period for most users.
• Months 9–18: slowing taper toward your effective dose plateau.
• After 18 months: maintenance phase — log weight every 1–2 weeks rather than weekly, and watch the trend window widen.

Insurance and Coverage Notes Worth Logging

Wegovy frequently requires prior authorization and re-authorization at intervals (often every 6 months). Keep your weight, dose, and adherence data ready for renewal. A clean log is often the difference between a smooth refill and a 3-week coverage gap.

Building Your Wegovy Doctor-Visit Summary

1. Current dose, last escalation date.
2. Total weight loss since baseline and rate over the last 12 weeks.
3. Adherence (doses taken vs. scheduled).
4. Top 3 side effects with severity trend.
5. Body measurement and photo summary.
6. Open questions — escalation, side-effect management, prior-authorization renewal.

On Wegovy, two pieces of paper matter most: the prescription itself and the running log you bring to follow-up. Together they answer almost every question that comes up in a typical visit.

Key Takeaways

• Wegovy uses a 16-week titration to 2.4 mg — log every escalation date.
• Missed-dose rule: if more than 2 days remain until the next dose, take it; otherwise skip.
• Track weight weekly, body measurements monthly, photos monthly.
• A quarterly summary is the highest-value output for clinician follow-ups and PA renewals.
• Consistency over a full year matters more than tracking precision in any single week.

If you are paying for a Wegovy tracker, pay for the parts that save real time: reminders, missed-dose context, side-effect trends, and a summary you can use at the next renewal or appointment.

Sources

• Wilding et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM.